Novocol Pharma is a global leader in sterile manufacturing, based in Cambridge, Ontario, Canada. As a Contract Development and Manufacturing Organisation (CDMO) with over 40 years of expertise, Novocol Pharma offers a comprehensive range of services tailored to meet the needs of the pharmaceutical and medical device industries. With a team of 600 skilled employees and state-of-the-art facilities, the company specializes in sterile injectable cartridge manufacturing, providing customer value through process scale-up, drug development, analytical services, technology transfer, and low to high volume commercial manufacturing of biologic and small molecule products. In 2024, Novocol Pharma will further enhance its capabilities by introducing expanded fill-finish services for Ready-to-Use (RTU) vials, pre-filled syringes, and cartridges, consolidating its position as a reliable partner in the industry.

Services include:
- Contract Development and Manufacturing (CDMO)
- Contract Manufacturing (CMO)
- Drug Delivery Devices
- Filling
- Cartridge
- Syringe
- Vials
- Process Development
- Manufacturing
- Aseptic Fill-Finish
- Clinical Trial Materials
- Dose Form
- Sterile
- Parenterals
- Project Management
- Finished Dosage Forms
- Biologics
- Medical Devices
- Analytical Services
- Stability Testing
- Drug-Device Assembly
- Drug Delivery System Design

As a full-service CDMO, Novocol Pharma is committed to providing high-quality, turnkey services that pharmaceutical and device companies can trust. To learn more about their offerings and capabilities, please visit novocolpharma.com.